GlaxoSmithKline neurology, autoimmune news

GSK will build an R&D center in China that will focus on neuroinflammatory and neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and multiple sclerosis (MS). The...